as on September 18, 2025 at 4:01 pm IST
Market Cap
₹774.33 Cr
Return on Equity (ROE)
18.99
PE Ratio (TTM)
3.15
Return on capital employed (ROCE)
20.55
Industry PE ratio
42.21
Beta (LTM)
0.61
P/B Ratio
0.63
Dividend Yield
0PEG Ratio
-0.05
Quarterly Earnings Growth YOY
756.44
EPS (TTM)
71.33
Sector
Pharmaceuticals
Book Value
157.64
Technical Analysis
Bullish
View Technical Analysis
as on September 18, 2025 at 4:01 pm IST
Ind-Swift Laboratories Ltd in the last 5 years
Lowest (-1795.00x)
December 8, 2022
Today (3.15x)
September 17, 2025
Industry (42.21x)
September 17, 2025
Highest (64.97x)
July 19, 2021
Today’s Price to Earnings Ratio: 3.15x
Compare market cap, revenue, PE, and other key metrics of Ind-Swift Laboratories Ltd with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| NA | 774.33 | 28.61% | 0.51 | 421 | 1,280 | |
| NA | 323.06 | 12.17% | 0.00 | 10 | 150 | |
| BUY | 11,519.78 | 5.09% | 0.00 | 485 | 2,386 | |
| NA | 1,315.39 | 2290.77% | 0.00 | 9 | 32 | |
| NA | 836.28 | -5.52% | 0.61 | 21 | 368 |
Search interest for Ind-Swift Laboratories Ltd Stock has decreased by -13% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
View detailed summary of the earnings and dividend history of Ind-Swift Laboratories Ltd.
Ind-Swift Laboratories Ltd’s net profit jumped 832.98% since last year same period to ₹8.77Cr in the Q1 2025-2026. On a quarterly growth basis, Ind-Swift Laboratories Ltd has generated -96.05% fall in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2011, Ind-Swift Laboratories Ltd has declared dividend of ₹1.00 per share on 25 May 2011 - translating a dividend yield of 1.90%.
Read More about DividendsInsights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Promoter Holding Up
![]()
Promoters have increased holdings from 36.77% to 37.72% in Aug 2025 quarter
Against Peers
![]()
In the last 3 years, Torrent Pharmaceuticals Ltd has given 139.7% return, outperforming this stock by 61.6%
Against Peers
![]()
In the last 1 year, Divis Laboratories Ltd has given 10.7% return, outperforming this stock by 34.2%
FII Holding Down
![]()
Foreign Institutions have decreased holdings from 16.99% to 16.68% in Aug 2025 quarter
Profit Down
![]()
Netprofit is down for the last 2 quarters, 222.27 Cr → 8.77 Cr (in ₹), with an average decrease of 96.1% per quarter
Price Dip
![]()
In the last 7 days, INDSWFTLAB stock has moved down by -2.7%
Retail Holding Down
![]()
Retail Investor have decreased holdings from 45.47% to 44.84% in Aug 2025 quarter
Revenue Fall
![]()
Revenue is down for the last 2 quarters, 358.57 Cr → 167.32 Cr (in ₹), with an average decrease of 53.3% per quarter
| Organisation | Ind-Swift Laboratories Ltd |
| Headquarters | Chandigarh |
| Industry | Pharmaceuticals |
| CEO | N R Munjal |
| E-voting on shares | Click here to vote |
Ind-Swift Laboratories Ltd share price today stands at ₹105.81 as on at the close of the market. Ind-Swift Laboratories Ltd share today touched a day high of ₹107 and a low of ₹104.
Ind-Swift Laboratories Ltd touched a 52 week high of ₹148.9 and a 52 week low of ₹68.72. Ind-Swift Laboratories Ltd share price today i.e. is closed at ₹105.81, which is -28.94% down from its 52 week high and 53.97% up from its 52 week low.
Ind-Swift Laboratories Ltd market capitalisation is ₹774.33 Cr as on .
To buy Ind-Swift Laboratories Ltd shares, you need to follow these steps:
Ind-Swift Laboratories Ltd trading volume is 42.74K as on . This means that 42.74K shares of Ind-Swift Laboratories Ltd were bought and sold on the stock market during today's trading session.